Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Proflavine × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01456143 2018-02-01

Optical Imaging of Head and Neck Cancer

Anandasabapathy, Sharmila, M.D.

Phase NA Terminated
33 enrolled 9 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡